Unique Platform Technology

➢ Design Stable Protein/peptide Drugs

- Prioprietary structural biology, protein sequence analysis, structure simulation, and unique protein digestion methods;

- Designed drug with better stability in vivo and half-life.

➢ Proven Drug Targets

- Extracellular domain of proven receptor targets as drug targets, such as PDGFR, TGFbetaR, TNFR, Her2/Neu receptors.

- Designed drugs competes with original ligand for the same receptor, and thus affect downstream signal transduction– similar mechanism to an antibody drug, more specific than a small molecule drug.

➢ Low cost and easy manufacturing

- Chemical synthesis or recombinant genetic engineering.